Yonehiro Grant sold 1,417 shares of Bolt Biotherapeutics, Inc. at $3.77 for −$5.35k on Sep 16, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Chief Operating Officer
Chief Operating Officer
Filed Sep 21, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$5,347.76Shares × reported price
Shares traded
1,417Common Stock
Price per share
$3.77Reported price. Read footnotes for ranges.
% of reported position traded
4.65%This security and ownership context
Holdings after
29,028Direct
Trade date
Sep 16, 2026Sell
Filed
Sep 21, 2026, 6:05 PM ET5-day reporting delay
Accession
0001193125-26-396894Code S · Transaction 227046
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 30,445 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Sep 17, 2026Sell4,909$3.32−$16,289.53Trade 227047
Sep 18, 2026Sell6,850$3.24−$22,169.34Trade 227048
3 transaction rows in this filing. Joint filers share the same rows.

BOLT price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
BOLT · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −17%1w ago 0%1d ago 0%
Returns since7d −10%30d +7.3%90d180d1y

Footnotes in full

F1: Represents weighted average sales price. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units granted on October 22, 2025. The shares were sold at prices ranging from $3.60 to $4.14. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the "SEC"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2: Represents weighted average sales price. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units granted on October 22, 2025. The shares were sold at prices ranging from $3.22 to $3.67. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the "SEC"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. F3: Represents weighted average sales price. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units granted on October 22, 2025. The shares were sold at prices ranging from $3.15 to $3.41. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the "SEC"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.